Catalyst Pharmaceuticals(US:CPRX) Globenewswireยท2025-10-09 12:03Core Insights - Catalyst Pharmaceuticals, Inc. is focused on developing and commercializing novel medicines for rare and difficult-to-treat diseases, with a commitment to patient care and accessibility [1][3]. Conference Presentations - Catalyst will present data at several upcoming scientific conferences, including the Child Neurology Society Annual Meeting and the American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting, showcasing real-world analyses related to Duchenne Muscular Dystrophy and Lambert Eaton Myasthenic Syndrome [2]. Company Overview - Catalyst Pharmaceuticals is recognized for its successful track record in bringing life-changing treatments to market and has been listed as one of America's Most Successful Mid-Cap Companies by Forbes in 2025 and one of North America's Fastest-Growing Companies by Deloitte in 2024 [3].